Prevention of Noise-induced Damage by Use of Antioxidants
Launched by UNIVERSITY HOSPITAL, ANTWERP · Nov 12, 2012
Trial Information
Current as of May 01, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 18-25 years old
- • Temporary tinnitus after noise exposure: loudness \>5 on a VAS
- Exclusion Criteria:
- • middle ear problems
- • Allergy for magnesium or n-acetylcystein
- • Use of hearing protection when going out
About University Hospital, Antwerp
University Hospital Antwerp is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, the hospital fosters a collaborative environment that integrates cutting-edge scientific inquiry with state-of-the-art medical practices. As a prominent sponsor of clinical trials, University Hospital Antwerp is committed to enhancing medical knowledge and improving treatment outcomes across a wide range of specialties, leveraging its expertise to contribute significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antwerp, Edegem, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials